Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)123-124
Number of pages2
JournalClinical and Molecular Hepatology
Volume23
Issue number2
DOIs
Publication statusPublished - 2017 Jun 1

Fingerprint

Phenylurea Compounds
Antineoplastic Combined Chemotherapy Protocols
Intra Arterial Infusions
Liver Neoplasms
Hepatocellular Carcinoma
Drug Therapy
sorafenib

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Molecular Biology

Cite this

@article{e5fd48305aad4ebcabac6ebcb6be9ab5,
title = "Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?",
author = "doyoung kim",
year = "2017",
month = "6",
day = "1",
doi = "10.3350/cmh.2017.0107",
language = "English",
volume = "23",
pages = "123--124",
journal = "Clinical and molecular hepatology",
issn = "2287-2728",
publisher = "Korean Association for the Study of the Liver",
number = "2",

}

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma? / kim, doyoung.

In: Clinical and Molecular Hepatology, Vol. 23, No. 2, 01.06.2017, p. 123-124.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?

AU - kim, doyoung

PY - 2017/6/1

Y1 - 2017/6/1

UR - http://www.scopus.com/inward/record.url?scp=85061424836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061424836&partnerID=8YFLogxK

U2 - 10.3350/cmh.2017.0107

DO - 10.3350/cmh.2017.0107

M3 - Editorial

C2 - 28669140

AN - SCOPUS:85061424836

VL - 23

SP - 123

EP - 124

JO - Clinical and molecular hepatology

JF - Clinical and molecular hepatology

SN - 2287-2728

IS - 2

ER -